Cardiovascular Systems - Stock Price History | CSII

Historical daily share price chart and data for Cardiovascular Systems since 2019 adjusted for splits. The latest closing stock price for Cardiovascular Systems as of October 22, 2019 is 46.90.
  • The all-time high Cardiovascular Systems stock closing price was 104.00 on August 08, 2006.
  • The Cardiovascular Systems 52-week high stock price is 52.54, which is 12% above the current share price.
  • The Cardiovascular Systems 52-week low stock price is 24.84, which is 47% below the current share price.
  • The average Cardiovascular Systems stock price for the last 52 weeks is 38.55.
Cardiovascular Systems Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 30.1094 24.2400 39.2500 21.0500 28.4900 20.26%
2017 28.1704 24.1100 32.8900 23.3650 23.6900 -2.15%
2016 18.1133 14.5800 27.1400 7.6700 24.2100 60.12%
2015 26.5858 29.5600 40.9800 13.5400 15.1200 -49.73%
2014 29.6898 33.2400 36.5900 23.6300 30.0800 -12.28%
2013 21.4619 12.9800 34.2900 12.9800 34.2900 173.23%
2012 10.0472 10.1500 12.8900 8.2800 12.5500 27.41%
2011 11.6191 11.7700 16.1000 7.4100 9.8500 -15.52%
2010 5.7042 4.5900 11.7500 3.8500 11.6600 154.03%
2009 7.1025 9.5000 10.3000 3.8400 4.5900 -50.65%
2008 13.9449 30.2000 30.2000 3.5000 9.3000 -70.00%
2007 54.2741 56.5000 70.0000 31.0000 31.0000 -45.99%
2006 83.9558 101.0000 104.0000 51.9000 57.4000 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.698B $0.248B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $144.308B 26.34
Medtronic (MDT) Ireland $143.049B 20.08
Stryker (SYK) United States $80.458B 27.82
Boston Scientific (BSX) United States $53.838B 26.11
Baxter (BAX) United States $45.159B 27.38
EssilorLuxottica Societe Anonyme (ESLOY) France $32.445B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.251B 18.08
Coloplast (CLPBY) Denmark $25.596B 40.86
Lonza Group Ag (LZAGY) Switzerland $25.453B 0.00
Terumo (TRUMY) Japan $24.836B 31.00
Smith & Nephew SNATS (SNN) United Kingdom $19.091B 0.00
ResMed (RMD) United States $18.765B 35.76
Sunny Optical Technology (SNPTF) China $16.387B 0.00
Bio-Rad Laboratories (BIO) United States $10.297B 55.20
Insulet (PODD) United States $9.275B 549.57
Perrigo (PRGO) Ireland $7.335B 13.51
Canopy Growth (CGC) Canada $7.079B 0.00
Hill-Rom Holdings (HRC) United States $6.788B 20.24
Haemonetics (HAE) United States $6.460B 48.76
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.231B 27.02
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.796B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.753B 0.00
NuVasive (NUVA) United States $3.507B 27.96
Neogen (NEOG) United States $3.413B 57.10
ICU Medical (ICUI) United States $3.189B 20.69
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.674B 0.00
Quidel (QDEL) United States $2.537B 25.19
Agios Pharmaceuticals (AGIO) United States $1.964B 0.00
National Vision Holdings (EYE) United States $1.818B 39.24
Aphria (APHA) $1.215B 0.00
VAREX IMAGING (VREX) United States $1.119B 25.79
AtriCure (ATRC) United States $1.026B 0.00
Phibro Animal Health (PAHC) United States $0.871B 14.17
Eagle Pharmaceuticals (EGRX) United States $0.852B 21.73
Omeros (OMER) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.752B 0.00
PetIQ (PETQ) United States $0.731B 17.26
Lantheus Holdings (LNTH) United States $0.722B 18.97
LeMaitre Vascular (LMAT) United States $0.707B 41.91
Cerus (CERS) United States $0.630B 0.00
Surmodics (SRDX) United States $0.603B 114.61
MacroGenics (MGNX) United States $0.556B 0.00
TG Therapeutics (TGTX) United States $0.524B 0.00
OraSure Technologies (OSUR) United States $0.505B 23.37
Quanterix (QTRX) United States $0.500B 0.00
Owens & Minor (OMI) United States $0.455B 13.64
Meridian Bioscience (VIVO) United States $0.426B 13.31
Utah Medical Products (UTMD) United States $0.365B 26.75
Zynex (ZYXI) United States $0.353B 37.52
BioLife Solutions (BLFS) United States $0.344B 105.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.317B 0.00
United Health Products (UEEC) United States $0.233B 0.00
Bovie Medical (APYX) United States $0.230B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Repro-Med Systems (REPR) United States $0.163B 0.00
Rockwell Medical (RMTI) United States $0.162B 0.00
Cytosorbents (CTSO) United States $0.151B 0.00
Female Health (VERU) United States $0.133B 0.00
Fonar (FONR) United States $0.131B 9.17
InfuSystems Holdings (INFU) United States $0.129B 0.00
Liberty Health Sciences (LHSIF) Canada $0.111B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
Chimerix (CMRX) United States $0.089B 0.00
United-Guardian (UG) United States $0.086B 20.37
Nephros (NEPH) United States $0.075B 0.00
MTech Acquisition (KERN) United States $0.060B 0.00
MRI Interventions (MRIC) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Surface Oncology (SURF) United States $0.038B 0.00
Senestech (SNES) United States $0.022B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00